biotech
Working Life: Dr Rav Seeruthun, Medical Director of Roche UK
December 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical
Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …
FDA launches new method for antibiotic prescription
December 14, 2017Medical Communications antibiotic resistance, biotech, drugs, pharma, pharmaceutical
The fight against the growth of antibiotic resistance has become a major talking point internationally in recent years and the …
What will Pfizer do with its second Remicade biosimilar?
December 14, 2017Sales and Marketing Ixifi, Johnson & Johnson, Pfizer, Remicade, biosimilars, biotech, drugs, inflectra, pharma, pharmaceutical
Pfizer is now in the unusual position of owning two biosimilars to Johnson & Johnson’s Remicade, though one of these …
Daiichi Sankyo: Two steps forward, one step back in cancer deals
December 14, 2017Sales and Marketing Daiichi Sankyo, biotech, drugs, pharma, pharmaceutical
Daiichi Sankyo had a busy day in terms of its deals in oncology, not only did it tear up its …
Sanofi sees pipeline fruition in 2018
December 13, 2017Research and Development Sanofi, biotech, drugs, pharma, pharmaceutical
In news that Sanofi will no doubt be hoping should divert attention away from the Dengvaxia scandal, the company revealed …
FDA cracks down on snortable chocolate powder
December 13, 2017Medical Communications, Research and Development FDA, biotech, drugs, pharma, pharmaceutical
The FDA has taken action on Coco Loko and Legal Lean Syrup, both made by Arco Globus Trading LLC, after …
Tumultuous times at Teva continue, with Chairman exit
December 13, 2017Medical Communications, Research and Development Teva, biotech, drugs, pharma, pharmaceutical
In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …
Latest US company accused of price gouging, after 2,469% increase
December 12, 2017Manufacturing and Production, Sales and Marketing Avondale Pharmaceutical, Niacor, biotech, drugs, pharma, pharmaceutical
It seems that no matter how much bad press comes their way, certain pharmaceutical companies are more than happy to …
Sanofi issues US-wide recall for arthritis product, after adverse events
December 12, 2017Manufacturing and Production Sanofi, Synvisc-One, biotech, drugs, pharma, pharmaceutical
Sanofi has announced a recall of 12,380 syringes of its Synvisc-One product for the treatment of osteoarthritis, after it was …
Ionis scores huge breakthrough in Huntington’s, Roche licenses drug
December 12, 2017Manufacturing and Production, Research and Development Ionis, Roche, biotech, drugs, pharma, pharmaceutical
Ionis Pharmaceuticals has revealed findings from its Phase 1/2a study into a treatment for Huntington’s disease and the strong data …
To succeed in emerging market medicine, anticipation and innovation are essential
December 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical
Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …
Teva job cut rumours resurface, 10,000 expected
December 11, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Only last month, the story broke that Teva was looking to cut away a number of employees, the rumours have …
NHS trust boss of major hospital hands in fiery resignation notice
December 11, 2017Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical
Bob Kerslake, now former chair of King’s College hospital, London, has handed in his resignation, citing the lack of long-term …
Top Ten most popular articles on Pharmafile.com this week
December 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, most read news, pharma, pharmaceutical, top ten
Despite us nearing the end of the year, the news has not been slowing down at all. Headlines across Europe …
Roche Tecentriq combo effective, but is it enough?
December 8, 2017Medical Communications, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
When Roche announced that its combination treatment of Tecentriq, alongside its own drug Avastin and chemotherapy, successfully extended progression-free survival …
